BRIEF published on 05/07/2025 at 17:54, 1 year 2 months ago SKAN Group AG Annual Meeting: All Board Proposals Approved Dividend Distribution Board Re-election Non-Financial Matters Remuneration Report SKAN Group AGM
PRESS RELEASE published on 05/07/2025 at 17:49, 1 year 2 months ago Annual General Meeting of SKAN Group AG approves all proposals Annual General Meeting of SKAN Group AG approves all proposals at their meeting in Allschwil, Switzerland. Board members re-elected and dividend distribution approved Annual General Meeting Board Members Dividend Distribution SKAN Group AG Allschwil
BRIEF published on 03/25/2025 at 06:05, 1 year 3 months ago SKAN Records Significant Profit and Order Growth in 2024 Sustainability Strategy Order Intake Increase EBITDA Margin Expansion SKAN Group Financial Growth Future Growth Investments
PRESS RELEASE published on 03/25/2025 at 06:00, 1 year 3 months ago SKAN with significant profit increase and strong order intake in the 2024 financial year SKAN reports significant profit increase and strong order intake in the 2024 financial year, with growth in order intake, net sales, and EBITDA. Dividend proposed at CHF 0.40 per share Financial Year Dividend Order Intake Profit Increase SKAN
BRIEF published on 01/22/2025 at 07:05, 1 year 6 months ago SKAN Reports Preliminary Figures for 2024 EBITDA Pharmaceutical Industry Net Sales SKAN Group AG 2024 Financial Figures
PRESS RELEASE published on 01/22/2025 at 07:00, 1 year 6 months ago SKAN announces preliminary key figures for the 2024 financial year SKAN Group AG announces preliminary key figures for the 2024 financial year revealing increased net sales and EBITDA. Detailed financial results will be released on March 25, 2025 EBITDA Net Sales 2024 Financial Year SKAN Group AG Preliminary Key Figures
BRIEF published on 08/20/2024 at 07:05, 1 year 11 months ago SKAN Group Reaches Its Targets in the First Half of 2024 Profitability Net Sales Growth Order Intake Half-year Results SKAN Group
PRESS RELEASE published on 08/20/2024 at 07:00, 1 year 11 months ago SKAN Group reaches its targets in the first half of 2024 SKAN Group AG achieves targets with net sales growth of 17.2% and EBITDA increase of 15.7% in the first half of 2024. Strong order intake and backlog, confirming guidance for full year Net Sales Growth Order Intake EBITDA Increase Guidance SKAN Group
BRIEF published on 05/31/2024 at 07:05, 2 years 1 month ago SKAN Increases Stake in Aseptic Technologies to 90 Percent Pharmaceutical Industry Stake Increase SKAN Aseptic Technologies AT-Closed Vial®
PRESS RELEASE published on 05/31/2024 at 07:00, 2 years 1 month ago SKAN increases stake in Aseptic Technologies to 90 percent SKAN Group AG increases its stake in Aseptic Technologies to 90%, reinforcing strategic importance. Aseptic Technologies specializes in AT-Closed Vial® Technology for cell and gene therapy applications Pharmaceutical Industry Stake Increase SKAN Group AG Aseptic Technologies AT-Closed Vial® Technology
Published on 07/22/2026 at 15:00, 9 hours 32 minutes ago Karbon-X Secures Technical Advisory Engagement for Nature-Based Carbon Project in Libya
Published on 07/22/2026 at 15:00, 9 hours 32 minutes ago Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF) Due to Microvillus Inclusion Disease (MVID)
Published on 07/22/2026 at 14:35, 9 hours 57 minutes ago Wi2Wi Reports Significant Manufacturing Yield Improvement in Q2 2026
Published on 07/22/2026 at 14:30, 10 hours 2 minutes ago As Ebola Death Toll Surpasses 930 Within Two Months, NanoViricides Has Applied to the DR Congo Regulatory Agency for Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola
Published on 07/22/2026 at 23:58, 34 minutes ago EQS-Adhoc: Deutsche Rohstoff AG: Increase in 2026 Guidance: EBITDA of approximately EUR 365 million expected
Published on 07/22/2026 at 22:20, 2 hours 11 minutes ago Quantinuum Appoints Chief Legal Officer and Chief People Officer
Published on 07/22/2026 at 21:01, 3 hours 30 minutes ago EQS-Adhoc: Correction of a release from 22/07/2026, 20:08 CET/CEST - FUCHS SE: Preliminary results for the first half of the year ahead of expectations and increase in the EBIT forecast for 2026
Published on 07/22/2026 at 20:44, 3 hours 48 minutes ago EQS-Adhoc: CHAPTERS Group AG: Successful Completion of Private Placement of the Capital Increase from Authorized Capital Resolved on July 22, 2026
Published on 07/22/2026 at 18:19, 6 hours 13 minutes ago Covivio successfully places €500 million of 7-year European Green Bonds
Published on 07/22/2026 at 17:45, 6 hours 47 minutes ago Groupe CRIT : 2026 first half revenue: €1.67 billion (+2.3% on an organic basis).
Published on 07/22/2026 at 17:40, 6 hours 52 minutes ago Report on share repurchases from 15 to 21 July 2026
Published on 07/22/2026 at 08:03, 16 hours 29 minutes ago Availability of the 2026 Interim Results Report
Published on 07/22/2026 at 08:00, 16 hours 32 minutes ago Neoen launches construction of Narrogin Wind Farm in Western Australia after signing PPA with Synergy
